Literature DB >> 32558053

The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study.

Bernardo Rocco1, Maria Chiara Sighinolfi2, Marco Sandri3, Vincenzo Altieri4, Michele Amenta5, Filippo Annino6, Alessandro Antonelli7, Raffaele Baio8, Riccardo Bertolo9, AldoMassimo Bocciardi10, Marco Borghesi11, Pierluigi Bove9, Giorgio Bozzini12, Eugenio Brunocilla13, Giovanni Cacciamani14, Alberto Calori12, Angelo Cafarelli15, Antonio Celia16, Antonio Carbone17, Andrea Cocci18, Alfio Corsaro19, Giovanni Costa16, Carlo Ceruti20, Luca Cindolo21, Simone Crivellaro22, Orietta Dalpiaz23, Daniele D'Agostino24, Bruno Dall'Oglio25, Donato Dente26, Roberto Falabella27, Mario Falsaperla28, Giovanni Ferrari29, Marinella Finocchiaro28, Simone Flammia30, Franco Gaboardi31, Antonio Galfano32, Fabrizio Gallo33, Lorenzo Gatti29, Francesco Greco4, Sada Khorrami34, Costantino Leonardo30, Carlo Marenghi35, Roberto Nucciotti36, Marco Oderda37, Vincenzo Pagliarulo38, Paolo Parma39, Antonio L Pastore40, Giovannalberto Pini31, Angelo Porreca41, Luigi Pucci42, Maurizio Schenone43, Riccardo Schiavina44, Carmine Sciorio45, Lorenzo Spirito46, Alessandro Tafuri47, Carlo Terrone48, Paolo Umari49, Virginia Varca50, Domenico Veneziano51, Paolo Verze52, Alessandro Volpe53, Salvatore Micali1, Lorenzo Berti54, Stefano Zaramella55, Luisa Zegna56, Elisabetta Bertellini57, Andrea Minervini58.   

Abstract

OBJECTIVE: To describe the trend in surgical volume in urology in Italy during the coronavirus disease 2019 (COVID-19) outbreak, as a result of the abrupt reorganisation of the Italian national health system to augment care provision to symptomatic patients with COVID-19.
METHODS: A total of 33 urological units with physicians affiliated to the AGILE consortium (Italian Group for Advanced Laparo-Endoscopic Surgery; www.agilegroup.it) were surveyed. Urologists were asked to report the amount of surgical elective procedures week-by-week, from the beginning of the emergency to the following month.
RESULTS: The 33 hospitals involved in the study account overall for 22 945 beds and are distributed in 13/20 Italian regions. Before the outbreak, the involved urology units performed overall 1213 procedures/week, half of which were oncological. A month later, the number of surgeries had declined by 78%. Lombardy, the first region with positive COVID-19 cases, experienced a 94% reduction. The decrease in oncological and non-oncological surgical activity was 35.9% and 89%, respectively. The trend of the decline showed a delay of roughly 2 weeks for the other regions.
CONCLUSION: Italy, a country with a high fatality rate from COVID-19, experienced a sudden decline in surgical activity. This decline was inversely related to the increase in COVID-19 care, with potential harm particularly in the oncological field. The Italian experience may be helpful for future surgical pre-planning in other countries not so drastically affected by the disease to date.
© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #COVID19; #Urology; #uroonc; COVID-19 outbreak; trend of variation; urological surgery

Mesh:

Year:  2020        PMID: 32558053      PMCID: PMC7322984          DOI: 10.1111/bju.15149

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.969


Introduction

In late December 2019, a cluster of unexplained cases of viral pneumonia occurred in Wuhan, China; on the 11 February 2020, the WHO officially named the disease caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) as coronavirus disease 2019 (COVID‐19), with its clinical presentation including a severe form of acute respiratory syndrome [1]. From the initial cluster, it rapidly spread to other countries. In Italy, the first patient, a healthy 38‐year‐old man, was diagnosed on the 18 February 2020 [2, 3]. Thirty days later, the virus had caused 47 021 known infections and 4032 deaths, the highest fatality rate in the world at the time. Italy faced the emergency at different levels, moving from the initial identification, tracking and isolation of cases, to public interventions for virus containment; however, the high hospitalisation rate, due to the severity of the clinical syndromes, as well as the need for intensive care units (ICUs), rendered hospital preparedness impossible in a real‐time fashion [2, 3, 4]. A month later, the Italian healthcare system, ranked as one of the best in the world according to the WHO, had been abruptly redesigned to face the uncontrolled COVID‐19 outbreak. The redefinition of Italian care delivery was based on the creation of spaces entirely dedicated to patients with COVID‐19, as novel triage areas; meanwhile, internal medicine wards, pre‐existing ICUs and most of the anaesthesiologists’ staff moved to the assistance of symptomatic and critically ill patients with COVID‐19 [2, 3, 4]. In addition, in more involved areas operating rooms (ORs) were converted into ICUs dedicated to patients with COVID‐19. As a drawback, non‐urgent procedures were almost completely cancelled, at both outpatient and inpatient level; lots of diagnostic and surgical procedures are still pending, including those for oncological diseases of different risk classes [2, 3, 4]. Due to this sudden reduction, the less involved, contiguous regions experienced a prompt increase in demands from patients in critical areas. Such demands posed the issue of how to manage potential asymptomatic, infected subjects within hospitals free from COVID‐19. Initially, specific protocols were used, but soon these requests were discouraged, as they were resource‐demanding. In such a context further dilemmas arose on how to preserve the basic rights of all citizens. Among surgical specialities, urology deals with the treatment of three highly frequent cancers, prostate, bladder, and kidney cancer [5]. Furthermore, it includes endourological procedures for the minimally invasive treatment of urolithiasis, a disease affecting up to 20% of the population in their lifetime [5]. Consequently, urology is one of the surgical specialties suffering most from the reduction in elective surgery, given the high burden of surgical activity and OR occupation. The aim of the present study was to describe how much, and how quickly the COVID‐19 outbreak affected the regular activity in the urological setting in Italy, a country paying a high price in terms of human lives as a result of the sudden pandemic.

Methods

We considered 33 urological centres with physicians affiliated to a consortium known as the AGILE group (Italian Group for Advanced Laparo‐Endoscopic Surgery; www.agilegroup.it). A description of each Centre (name of the author, city, region, name of the hospital, bed availability, academic vs non‐academic, and public vs private) is provided in Table 1. All centres perform open and minimally invasive surgery (endourology, laparoscopic and or robotic surgery). By the 15 March 2020, an e‐mail questionnaire (Appendix 1) was sent to the aforementioned AGILE urologists, asking for a timely completion. The survey aimed to evaluate possible variations in the burden of surgical activity during the month following the first COVID‐19 case in Italy.
Table 1

Characteristics of the surveyed Italian centres (name of the Author, region, city, name of the Institution, bed availability, academic vs non‐academic, and public vs private).

AuthorRegionCityInstitutionUrology staff members, n Beds, n Academic vs non‐academicPublic vs private
AmentaVenetoPortogruaroAzienda ULSS n.4 Veneto Orientale9240Non‐academicPublic
AnninoTuscanyArezzoOspedale San Donato, AUSL 89510Non‐academicPublic
AntonelliVenetoVeronaOspedale Maggiore Borgo Trento15682AcademicPublic
BorghesiLiguriaGenovaOspedale San Martino151400AcademicPublic
BoveLazioRomeOspedale San Carlo di Nancy di Roma7230AcademicPublic
BozziniLombardyBusto ArsizioASST Valle Olona121564Non‐academicPublic
CaffarelliMarcheAnconaVilla Igea6224Non‐academicPrivate
CeliaVenetoBassanoOspedale San Bassiano11406Non‐academicPublic
CerutiPiedmontTurinAOU Città della Salute e della Scienza di Torino221481AcademicPublic
CindoloEmilia RomagnaModenaHesperia Hospital12125Non‐academicPrivate
CindoloLazioRomeVilla Stuart250Non‐academicPrivate
FalabellaBasilicataPotenzaSan Carlo di Potenza7500Non‐academicPublic
FalsaperlaSicilyCataniaARNAS Garibaldi Hospital, Catania,91000Non‐academicPublic
GalfanoLombardyMilanASST Grande Ospedale Metropolitano Niguarda101213Non‐academicPublic
GalloLiguriaSavonaOspedale San Paolo di Savona10472Non‐academicPublic
GrecoLombardyBergamoHumanitas Gavazzeni8311Non‐academicPrivate
LeonardoLazioRomePoliclinico Umberto I111200AcademicPublic
MinerviniTuscanyFlorenceAOU Careggi261309AcademicPublic
NucciottiTuscanyGrossetoAzienda USLToscana Sud Est6445Non‐academicPublic
PagliaruloApuliaLecceOspedale Vito Fazzi81249Non academicPublic
ParmaLombardyMantovaOspedale Carlo Poma10628Non‐academicPublic
PastoreLazioLatinaSapienza University4341AcademicPublic
PiniLombardyMilanSan Raffaele Turro17188Non‐academicPrivate
PorrecaVenetoAbano termePoliclinico Abano Terme7205Non‐academicPrivate
PucciCampaniaNaplesAzienda Ospedaliera A. Cardarelli16850Non‐academicPublic
RoccoEmilia RomagnaModenaAzienda Ospedaliero Universitaria di Modena121108AcademicPublic
SchiavinaEmilia RomagnaBolognaAOU Policlinico Sant‐Orsola‐Malpighi161487AcademicPublic
SciorioLombardyLeccoASST Ospedale Manzoni7750Non‐academicPublic
VarcaLombardyGarbagnateASAT Rhodense Ospedale Guido Salvini di Garbagnate6539Non‐academicPublic
VenezianoCalabriaReggio CalabriaAO Bianchi‐Melacrino‐Morelli9600Non‐academicPublic
VerzeCampaniaSalernoAOU San Giovanni di Rio e Ruggi d'Aragona6642AcademicPublic
VolpePiedmontNovaraOspedale Maggiore della Carità9711AcademicPublic
ZaramellaPiedmontBiellaOspedale degli Infermi7490Non‐academicPublic
Characteristics of the surveyed Italian centres (name of the Author, region, city, name of the Institution, bed availability, academic vs non‐academic, and public vs private). Time trend of OR activity was collected over 4 consecutive weeks (24/02/2020 to 01/03/2020; 02/03/2020 to 08/03/2020; 09/03/2020 to 15/03/2020; 16/03/2020 to 22/03/2020). As a reference, we asked them to provide data on the weekly regular OR occupation before the 22 February 2020. We report a list of items that were addressed in the survey: The overall number of procedures performed each week; we included all procedures under general and spinal anaesthesia and emergency procedures The overall number of OR sessions each week (considering a single session from 08:00 to 14:00 hours or 14:00 to 20:00 hours) The number of oncological and non‐oncological procedures The number of health professionals with laboratory‐confirmed COVID‐19 and therefore, not allowed to work The primary endpoint was to assess the overall trend of surgical activity, measured as the number of surgical procedures performed each week, compared to the baseline regular week. As a secondary endpoint, we addressed the trend of OR occupation stratified by geographical areas (Fig. 1), divided into:
Fig. 1

Map of geographical stratification: Centres from Lombardy (seven Centers) (dark grey). Centres from northern regions bordering with Lombardy with COVID‐19 presence as by (Piedmont, Emilia‐Romagna, Veneto; 10 Centres) (grey). Centres from other Italian regions (16 Centers) (white).

Centres from Lombardy (seven centres) Centres from northern regions bordering with Lombardy, with COVID‐19 presence (Piedmont, Emilia‐Romagna, Veneto; 10 centres) Centres from other Italian regions (16 centres) Map of geographical stratification: Centres from Lombardy (seven Centers) (dark grey). Centres from northern regions bordering with Lombardy with COVID‐19 presence as by (Piedmont, Emilia‐Romagna, Veneto; 10 Centres) (grey). Centres from other Italian regions (16 Centers) (white). Data on the percentage reduction of procedures per week, calculated with reference to the pre‐infection numbers, were summarised as median and interquartile range (IQR). Box plots depict the distributions of procedure reduction for the 33 centres, stratified by time interval and geographical area. Data related to overall incidence of COVID‐19 and hospitalisation were retrieved from the Protezione Civile database.

Results

The 33 urological centres, members of the AGILE group, are located in facilities with a overall bed availability of ~23 000 beds, distributed in 13 out of 20 Italian regions, including the 10 most populated regions. Before the COVID‐19 outbreak, the urology departments of the AGILE’s affiliated urologists performed an overall 1213 procedures in a standard working week in 2020, distributed over 375 OR sessions. Oncological procedures accounted for ~50% of overall activity. A month later, the median (IQR) number of urological surgical procedures had declined by 78% (60–91%). The trend appears inversely related to the increased COVID‐19‐related care, in terms of hospitalisation and ICUs bed occupation (source: protezionecivile.gov.it; Fig. 2).
Fig. 2

Overall Italian trend of elective surgery among urological involved centres (percentage variation from the pre‐infection baseline status). Trend of COVID‐19‐related care in Italy, defined as hospitalisation and ICU‐bed occupation (whisker extending from minimum to maximum). Red line: trend of variation of surgical procedures. Blue line: (continuous) number of new diagnosis. blue line: (dotted) number of hospitalised patients. Feb, February; Mar, March; k, thousand of cases.

Overall Italian trend of elective surgery among urological involved centres (percentage variation from the pre‐infection baseline status). Trend of COVID‐19‐related care in Italy, defined as hospitalisation and ICU‐bed occupation (whisker extending from minimum to maximum). Red line: trend of variation of surgical procedures. Blue line: (continuous) number of new diagnosis. blue line: (dotted) number of hospitalised patients. Feb, February; Mar, March; k, thousand of cases. The variation in terms of surgical activity, according to oncological and non‐oncological indications was 35.9% and 89%, respectively. Lombardy, the first region with laboratory‐confirmed presence of COVID‐19, experienced a 94% (IQR 85–100%) decline in elective surgery (Fig. 3a); with a 73% (IQR 63–86%) and 78% (IQR 53–91%) decrease in the regions neighbouring Lombardy and for other regions of Italy, respectively (Fig. 3b,c).
Fig. 3

Trend of elective surgery among urological involved centres stratified by area (A: Lombardy; B: regions neighbouring Lombardy; C: other regions). Box plots indicate the variability of surgical volumes between centres at different time frames (whisker extending from minimum to maximum). Feb, February; Mar, March; k, thousand of cases.

Trend of elective surgery among urological involved centres stratified by area (A: Lombardy; B: regions neighbouring Lombardy; C: other regions). Box plots indicate the variability of surgical volumes between centres at different time frames (whisker extending from minimum to maximum). Feb, February; Mar, March; k, thousand of cases. The time trends showed some interesting differences between Lombardy and other regions. Lombardy had a marked reduction in elective activity from the beginning of the emergency, while other regions experienced a similar reduction but delayed by 2 weeks following COVID‐19 diffusion. Of note, the re‐modulation of the OR schedules was not homogeneous; Fig. 3 shows (as box plots) the variability of surgical volumes between centres at different time frames, stratified by geographical area (Fig. 3A–C). A wide variability appeared at the beginning of the epidemic in Lombardy (Fig. 3A) and was still sustained 4 weeks later for distant regions (C), maybe reflecting regional variability of healthcare delivery and measures against COVID‐19. For regions neighbouring Lombardy (B), there was a homogenous reduction of surgical volumes among centres, maybe reflecting common measures and prompt alignment of the surgical activity. As far as the urological workforce was concerned, at 1 month after the COVID‐19 outbreak only seven of 341 (2%) urologists at the involved centres had a laboratory‐confirmed infection.

Discussion

One month after the first case in Italy, >4000 people had passed away from COVID‐19, 18 675 had been hospitalised and 2655 had been admitted to ICUs (source: protezionecivile.gov.it). The healthcare system was getting more and more overwhelmed, thus, elective and semi‐elective surgery decreased by 78% in the centres involved in our present study. The decline in the volume of surgery is mainly attributable to the sudden re‐organisation of facilities and human resources to accommodate symptomatic and critically ill patients with COVID‐19. The hospitalisation rate for COVID‐19 is roughly 50% of the infected, of whom 16% require ICUs [3], leading to a lack of workers, beds and ORs for elective or semi‐elective patients. The workforce shortage may be related to their diversion to other activities, as happened for the anaesthesiologists, who were mostly diverted into the ICUs from the very beginning of the emergency. Furthermore, healthcare workers are seriously prone to infections, deriving from either caregiving or other daily activities, such as managing instruments, touching computers, seeing outpatients [4]. By the 19 March 2020, a total of 3559 healthcare workers were infected, representing 8.3% of overall COVID‐19‐positive cases in Italy (source: gimbe.org). As far as our present study is concerned, only 2% of the urology staff from the involved centres had a laboratory‐confirmed infection at the time of the survey, indicating a relatively limited involvement of urologists in dealing with highly suspected or COVID‐19‐positive patients. It is important to note that according to Italian laws, healthcare workers were not tested for COVID‐19 if asymptomatic. Contrary to other specialities, in our present series the dramatic reduction in surgical procedures was not a consequence of surgeons’ who were becoming infected, but to the diversion of human resources. The Italian urological surgery scenario had dramatically changed at 1 month after the COVID‐19 outbreak. An overall reduction in OR sessions of 40.2% was documented, with the amount of oncological procedures being reduced by 35.9%. Non‐oncological surgery suffered decreases as high as 89%. Cancellations were performed homogeneously in centres according to an emergency/urgency principle: trauma, testicular torsion, urinary tract decompression were prioritised together with testicular and urothelial cancer. Considering the Italian areas included in the present survey, the geographical trend of the decline in surgical activity seems to be inversely related to the COVID‐19 topographical spread. The first and most involved region, Lombardy, responded to the outbreak with massive prioritisation of urgent care request, which 1 month later, translated into an abrupt shortage of OR occupation. Only 24 patients were actively scheduled among the seven AGILE Centres in Lombardy, previously accounting for 229 procedures per week, representing a reduction of nearly 90%. Analysing private and public clinical practice separately, we should also mention that three out of six private clinics experienced a complete slowdown of elective surgery during the emergency. The trend of COVID‐19 outbreak of other European countries (source: gimbe.org) and ultimately of the USA (source: Worldometers.info, Fig. 4) follows that of Lombardy, with similar curves, but with an evident, likely profitable, delay in time.
Fig. 4

Curves and time‐line trend of COVID‐19 outbreak in Italy and in the USA (source of data: worldometers.info). The USA trend reflects the Italian one with a delay of roughly 9 days.

Curves and time‐line trend of COVID‐19 outbreak in Italy and in the USA (source of data: worldometers.info). The USA trend reflects the Italian one with a delay of roughly 9 days. The knowledge of the disease trend and its drawbacks on healthcare may provide guidance for a timely and efficient re‐planning of facilities, in order to avoid or limit the massive breakdown of surgical activity too [6, 7]. Particularly, oncological patients may suffer from the consequences related to this delay that at the moment seem hardly predictable: The upgrading and upstaging of diseases may compromise the window of curability, or at least, determine the need for a higher number or quantity of therapies, potentially increasing side‐effects and affecting the patients’ functional outcomes. Based on the Italian experience, in our opinion, some actions could be pre‐planned to limit the burden of shortcomings: Adhere to the empirically suggested Surgical Priority Charts (as the ones from the Cleveland Clinic [8], from the BJU International [9] and from the European Urology community [10, 11], for the urology field) Create COVID‐19‐free healthcare facilities dedicated to patients undergoing major elective surgery (e.g. oncological or cardiovascular surgery) Possible advantages of creating COVID‐19‐free facilities: Preserving healthcare workers, allowing them to assist more patients Avoiding the risk of nosocomial infections of those patients who, being affected by other diseases would be more prone to an ominous response to the infection Preservation of a COVID‐19‐free Unit might be hard, as reported by Rosembaum et al. [4]; the virus containment within a single institution is difficult or impossible, because ‘the infection is likely to be everywhere in the hospital’, despite the provision and use of personal protective equipment (PPE); therefore, preserving COVID‐19‐free facilities rather than COVID‐19‐free areas inside a facility might be the key. For this purpose, important steps might be: To improve the knowledge of the disease and train healthcare workers accurately To improve healthcare workers’ safety, with timely and precise assignment of appropriate PPE and by regular testing of healthcare workers Patients’ remote pre‐triage on their health status (e.g. fever, symptoms etc.) and possibly pre‐quarantining and testing of the patients before allowing them inside the facility To minimise, or forbid the access to visitors To our knowledge this is the first report that describes the modifications of regular clinical activities due to the COVID‐19 pandemic, outside China. Italy, the hardest‐hit country in the world by COVID‐19, for cultural, social and political reasons, can be a more representative model than China, for Western countries, on how the COVID‐19 pandemic can impact the healthcare system. Strong and quick social restrictions, together with careful and appropriate healthcare planning might help to reduce the impact of the pandemic in other countries.

Conflict of Interest

The authors have no conflicts to disclose.

Sources

World Health Organization (who.int) Protezione Civile, Italia (protezionecivile.gov.it) https://www.google.com/url?q=http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html%23/b0c68bce2cce478eaac82fe38d4138b1&sa=D&ust=1584897912453000&usg=AFQjCNFF470yYK4NHGbRKAKE2wyxwTiXww GIMBE: evidence for Health (gimbe.org) Worldometer ‐ real time world statistics (worldometers.info) Agile group consortium ((Italian Group for Advanced Laparo‐Endoscopic Surgery) coronavirus disease 2019 intensive care unit interquartile range operating room personal protective equipment severe acute respiratory syndrome coronavirus‐2
  8 in total

1.  Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.

Authors:  Lisa Rosenbaum
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

2.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Defining the Epidemiology of Covid-19 - Studies Needed.

Authors:  Marc Lipsitch; David L Swerdlow; Lyn Finelli
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

4.  Priorities for the US Health Community Responding to COVID-19.

Authors:  Amesh A Adalja; Eric Toner; Thomas V Inglesby
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

Review 5.  COVID-19 and urology: a comprehensive review of the literature.

Authors:  Stefano Puliatti; Ahmed Eissa; Radwa Eissa; Marco Amato; Elio Mazzone; Paolo Dell'Oglio; Maria Chiara Sighinolfi; Ahmed Zoeir; Salvatore Micali; Giampaolo Bianchi; Vipul Patel; Peter Wiklund; Rafael F Coelho; Jean-Christophe Bernhard; Prokar Dasgupta; Alexandre Mottrie; Bernardo Rocco
Journal:  BJU Int       Date:  2020-05-12       Impact factor: 5.588

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Recommendations for Tiered Stratification of Urological Surgery Urgency in the COVID-19 Era.

Authors:  Howard B Goldman; George P Haber
Journal:  J Urol       Date:  2020-04-03       Impact factor: 7.450

8.  Endourological Stone Management in the Era of the COVID-19.

Authors:  Silvia Proietti; Franco Gaboardi; Guido Giusti
Journal:  Eur Urol       Date:  2020-04-14       Impact factor: 20.096

  8 in total
  16 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  When technological innovations do not reach consensus: the case of tele-consultation of andrological patients.

Authors:  Paolo Verze; Tommaso Cai; Gianni Malossini; Truls E Bjerklund Johansen; Raffaele Baio; Alessandro Palmieri
Journal:  Int J Impot Res       Date:  2020-08-25       Impact factor: 2.896

3.  COVID-19 and the urological practice: changes and future perspectives.

Authors:  Łukasz Nowak; Wojciech Krajewski; Paweł Kiełb; Anna Śliwa; Aleksandra Zdrojowy-Wełna; Romuald Zdrojowy
Journal:  Cent European J Urol       Date:  2020-08-01

Review 4.  [Organoids for the advancement of intraoperative diagnostic procedures].

Authors:  N Harland; B Amend; N Lipke; S Y Brucker; F Fend; A Herkommer; H Lensch; O Sawodny; T E Schäffer; K Schenke-Layland; C Tarín Sauer; W Aicher; A Stenzl
Journal:  Urologe A       Date:  2021-07-13       Impact factor: 0.639

Review 5.  Planning of surgical activity in the COVID-19 era: A proposal for a step toward a possible healthcare organization.

Authors:  Bernardo Rocco; Alessandra Bagni; Elisabtta Bertellini; Maria Chiara Sighinolfi
Journal:  Urologia       Date:  2020-07-15

Review 6.  [COVID-19 in european urology : Which lessons have we learned?]

Authors:  J J Rassweiler; G Pini; F Liatsikos; M Georgiev; M Roupret; A Breda; T Knoll; S Micali; A Stenzl; A S Goezen; K Yanev; M-C Rassweiler-Seyfried
Journal:  Urologe A       Date:  2021-02-08       Impact factor: 0.639

7.  Anosmia and ageusia: a piece of the puzzle in the etiology of COVID-19-related transitory erectile dysfunction.

Authors:  R Bertolo; C Cipriani; P Bove
Journal:  J Endocrinol Invest       Date:  2021-01-29       Impact factor: 5.467

8.  Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.

Authors:  Giampaolo Siena; L Cindolo; G Ferrari; D Maruzzi; G Fasolis; S V Condorelli; F Varvello; F Visalli; S Rabito; S Toso; S Caroassai; A Mari; L Viola; B K Somani; M Carini
Journal:  World J Urol       Date:  2021-03-31       Impact factor: 4.226

9.  To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic.

Authors:  Nina N Harke; Jan P Radtke; Boris A Hadaschik; Christian Bach; Frank P Berger; Andreas Blana; Hendrik Borgmann; Florian A Distler; Sebastian Edeling; Tobias Egner; Christina L Engels; Mahmoud Farzat; Alexander Haese; Rainer Hein; Markus A Kuczyk; Andreas Manseck; Rudolf Moritz; Michael Musch; Inga Peters; Sasa Pokupic; Bernardo Rocco; Andreas Schneider; André Schumann; Christian Schwentner; Chiara M Sighinolfi; Stephan Buse; Jens-Uwe Stolzenburg; Michael C Truß; Michael Waldner; Christian Wülfing; Volker Zimmermanns; Jörn H Witt; Christian Wagner
Journal:  PLoS One       Date:  2020-09-15       Impact factor: 3.240

Review 10.  Avoiding disruption of timely surgical management of genitourinary cancers during the early phase of the COVID-19 pandemic.

Authors:  Giuseppe Quarto; Giovanni Grimaldi; Luigi Castaldo; Alessandro Izzo; Raffaele Muscariello; Sonia De Sicato; Dario Franzese; Fabio Crocerossa; Paola Del Prete; Umberto Carbonara; Riccardo Autorino; Sisto Perdonà
Journal:  BJU Int       Date:  2020-08-06       Impact factor: 5.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.